Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.84 USD | -3.37% | -1.74% | +8.07% |
Financials (USD)
Sales 2024 * | 208M | Sales 2025 * | 120M | Capitalization | 1.5B |
---|---|---|---|---|---|
Net income 2024 * | 44M | Net income 2025 * | -6M | EV / Sales 2024 * | 5.35 x |
Net cash position 2024 * | 388M | Net cash position 2025 * | 637M | EV / Sales 2025 * | 7.18 x |
P/E ratio 2024 * |
35.8
x | P/E ratio 2025 * |
-31.7
x | Employees | 112 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | -4.28% | ||
1 week | +0.51% | ||
Current month | -11.16% | ||
1 month | -8.31% | ||
3 months | +4.73% | ||
6 months | +80.35% | ||
Current year | +12.08% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 24.75 | -3.70% | 140 286 |
24-04-24 | 25.7 | -4.28% | 326,485 |
24-04-23 | 26.85 | +0.90% | 339,333 |
24-04-22 | 26.61 | +3.90% | 296,277 |
24-04-19 | 25.61 | +1.55% | 452,407 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.08% | 1.5B | |
+4.09% | 43.84B | |
+46.73% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- PTGX Stock